L & L Energy Stock Gaps Up On Today's Open (LLEN)

NEW YORK ( TheStreet) -- Shares of L & L Energy (Nasdaq: LLEN) were gapping up Wednesday morning with an open price 13.5% higher than Tuesday's closing price. The stock closed at $2.29 Tuesday and opened today's trading at $2.60.

The average volume for L & L Energy has been 287,200 shares per day over the past 30 days. L & L Energy has a market cap of $92.9 million and is part of the basic materials sector and metals & mining industry. Shares are down 0.4% year to date as of the close of trading on Tuesday.

L&L Energy, Inc., through its subsidiaries, engages in the coal mining, clean coal washing, coal coking, and coal wholesale businesses in the People's Republic of China. The company offers thermal or steam coal. The company has a P/E ratio of 7.3, above the average metals & mining industry P/E ratio of 6.9 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates L & L Energy as a hold. The company's strengths can be seen in multiple areas, such as its attractive valuation levels and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. You can view the full L & L Energy Ratings Report.

Get more investment ideas from our investment research center.

Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting UP to 95370 or select from multiple alert options.

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing